Home - Clinakos

Rare Disease & Oncology Insights with Integrated Patient Data™ and Medically Smart AI™ Agents

Transformative approach with Fit-For-Purpose Patient Data Repositories and AI Agents for over 1500 Indications

Why Clinakos?

The Intelligence Gap in Rare Disease & Oncology

56%

Drug launches fail to meet expectations

50%+

Rare diseases lack dedicated coding

81%

Screened patients are ineligible for trials

80%

Of rare disease trials experience recruitment failure

Traditional data sources (claims databases, registries, tokenized datasets) were never designed for rare diseases, oncology and niche populations.

The Clinakos Advantage

13+

Years of Experience

Deep expertise in rare disease and oncology

1,500+

Disease Indications

Working directly with patients and providers

10+

Fit-For-Purpose AI Agents

specially trained for rare disease and oncology use cases

Indication-specific depth de-risks clinical trial design, optimizes patient selection, and grounds go-to-market strategy in evidence rather than extrapolation

The cost of being wrong is not just financial but human

The question isn’t whether you can afford specialized intelligence—it’s whether you can afford to launch without it.

What We Offer

Our comprehensive platform combines curated patient data with advanced AI tools, built on 13+ years of expertise in rare disease and oncology analytics

Clinakos Platform

With over 15 years of experience building and refining our platform, Clinakos brings deep domain expertise and proven credibility in rare disease and oncology analytics.

Medically Smart AI™

Ask questions and get intelligent answers powered by AI agents

Clarion™

Self-service analytics for advanced data exploration

Acceleron™

AI-powered diagnosis verification that confirms patient diagnoses and identifies patients meeting specific inclusion/exclusion criteria for clinical trials, market research, and medical coding validation.

Confirmis™

Integrated Patient Data™

Foundation Layer

Our platform links fragmented primary sources—including EMR, Claims, labs, prescriptions, and SDOH—with patient-generated information like PROs (Patient Reported Outcomes) and surveys. This creates comprehensive, de-identified patient profiles that provide a "360-degree" view of the patient journey.

Ability to Build Your Own Intelligence Solution

Build Your Own Patient Data Network and Registries, providing a comprehensive "one-stop shop" for the data infrastructure, analytics platform, and AI-powered tools required to serve all your rare disease and oncology intelligence needs. Whether you're establishing disease-specific registries, creating custom cohorts, or building longitudinal patient networks, Clinakos delivers the complete technology stack and data foundation to power your strategic initiatives from discovery through commercialization.

Who We Serve

From clinical development to real world evidence to commercialization, our platform enables breakthrough treatments for diseases of high unmet medical need

We serve established and specialized pharma and biotech firms dedicated to rare diseases, oncology, and niche sub-populations by providing the data and AI tools necessary for:

Clinakos offers the unique ability for organizations to Build Your Own Patient Data Network and Registries, allowing for customized data collection and long-term monitoring of specific niche populations

We support providers and healthcare systems in delivering precision patient-centric care with highly effective solutions, like:

Confirmation of Diagnosis: Help validate patient diagnoses through comprehensive multi-modal patient data review and applying learnings from our extensive database of patient journeys.

Medication Reconciliation: Track and reconcile medications across care settings to reduce errors and improve patient safety.

Patient Insights: Gain a unified view of fragmented patient journeys and tools to monitor long-term health and improve retention.

We partner with consulting firms and advisory organizations, enabling them to become trusted extensions of their biopharma clients. By subscribing to our data assets and AI-powered analytics tools, these partners can embed Clinakos intelligence into their own services — delivering deeper insights, accelerating evidence generation, and enhancing commercial and patient-centric strategies for their clients.

Clinakos offers the unique ability for organizations to Build Your Own Patient Data Network and Registries, allowing for customized data collection and long-term monitoring of specific niche populations

Our Customers

Trusted by leading pharmaceutical and biotech companies advancing rare disease and oncology treatments

What Our Customers Are Saying

Data has a story, a story of patients and of pharma’s impact on patients. We have been knocking on physician’s doors to learn some of this. You’ve been able to give us answers about our franchise we couldn’t find anywhere.

Life Science Market Research Executive

A leading Top Tier Pharmaceutical Company

The Medically Smart AI™ tools have transformed how we approach patient identification and diagnosis verification. What used to take weeks now takes days and sometimes hours.

Chief Executive Officer

A Leading Rare Disease Company

This is a gift that will keep giving, because if we have a question, we just have to go and ask it, you will come up with the answer. You have everything in your hand, you didn’t lose anything by missing out on some question you did not write prospectively before you started asking these queries. So that’s another important aspect that’s going to be different here. And it’s a game changer.

Franchise Head

Leading Top Tier Oncology Company

Featured By

Recognized by leading industry publications and media outlets

Ready to Access Rare Disease and Oncology Insights?

Discover how Clinakos can accelerate your drug development and commercialization with curated patient data and Medically Smart AI™.